Holen Sie sich die Stockscreener-App
64.60
2.75%
-1.83
Handel nachbörslich:
64.60
Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten
Is This a Bottoming Phase for Prestige Consumer Healthcare Inc.Market Activity Report & AI Forecasted Entry and Exit Points - beatles.ru
Prestige Consumer Healthcare Cuts FY22 Revenue Outlook Amid Supply Chain Issues and Retail Order Volatility - AInvest
Prestige Consumer Healthcare (PBH) Trims Outlook as Sales Dip—Is the Acquisition Strategy Still on Track? - simplywall.st
Prestige Consumer Healthcare's Strategic Acquisition and Q1 Earnings: A Value Investment Case in a Resilient OTC Sector - AInvest
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its First-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
Prestige Consumer Healthcare Acquires Pillar5 Pharma for Expansion - MSN
Prestige Consumer Healthcare: Analyst Maintains Buy Rating, Lowers Price Target to $100.00 - AInvest
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q1 2026 Earnings Call Transcript - Insider Monkey
Prestige Consumer Starting Clear Eyes Production With No Contract Partner ‘Out There To Tap Into’ - insights.citeline.com
Prestige Consumer Healthcare's Q1 2026: Key Contradictions in Clear Eyes Supply, Market Share, and Margin Outlook - AInvest
Prestige Consumer Healthcare stock hits 52-week low at 64.83 USD By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare stock hits 52-week low at 64.83 USD - Investing.com Nigeria
Prestige Brands stock price target lowered to $100 at Canaccord on eye care supply issues - Investing.com Canada
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $100 - 富途牛牛
Prestige Consumer Healthcare's Strategic Path to Recovery: Can Shareholders Capitalize on a Turnaround in Eye Care and Margin Expansion? - AInvest
Prestige Consumer Healthcare: Fiscal Q1 Earnings Snapshot - Manistee News Advocate
Prestige Consumer Healthcare: Strategic Acquisitions and Innovation Drive Long-Term Value Creation - AInvest
Prestige Consumer Healthcare outlines $1.1B-$1.115B FY26 revenue target amid Pillar5 acquisition and Clear Eyes supply recovery - MSN
Prestige Consumer Healthcare 2026 Q1 Earnings Misses Targets as Net Income Falls 3.3% - AInvest
Prestige Consumer Healthcare Q1 Earnings and Strategic Acquisition of Pillar5 Pharma - AInvest
Prestige Consumer Healthcare’s Q1 Earnings and Strategic Moves - TipRanks
Prestige Earnings: Clear Eyes' Constraints Cloud Near-Term Outlook, but Core Portfolio Remains Solid - Morningstar
Prestige Consumer Healthcare Q1 2026 Earnings Call Transcript - MarketBeat
Prestige Consumer Healthcare shares fall 10.14% intraday after missing Q1 revenue estimates and lowering fiscal 2026 outlook. - AInvest
Prestige Consumer Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Prestige Consumer Healthcare Inc. Q1 Profit Decreases, Misses Estimates - Nasdaq
Prestige Consumer Healthcare Plummets 10.5%: Earnings Shock and Sector Turbulence Ignite Sell-Off - AInvest
Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Prestige Consumer Healthcare's Strategic Acquisition of Anjac SAS: A Catalyst for OTC Men's Health Dominance - AInvest
Prestige Consumer Healthcare Eyes Growth Despite Revenue Shortfall - Finimize
Prestige Consumer Healthcare on Aug 4, unit entered agreement with Anjac SASSEC filing - MarketScreener
Prestige Consumer Healthcare Q1 FY26 slides: Revenue drops on supply issues, margins improve - Investing.com Nigeria
Prestige Consumer Healthcare Q1 FY26 slides: Revenue drops on supply issues, margins improve By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare (PBH) Misses Q1 Earnings and Revenue Estimates - Yahoo Finance
Prestige Consumer Healthcare Q1 Revenue Falls 6.6% Amid Supply Constraints and Order Timing Shifts - AInvest
Prestige Consumer Healthcare's Strategic Acquisition of Pillar5 Pharma: A Masterstroke in Supply Chain Resilience and Competitive Edge - AInvest
Prestige Consumer Healthcare Reports Lower Q1 Earnings Than ExpectedNews and Statistics - IndexBox
Prestige (PBH) Q1 Revenue Falls 6.6% - The Globe and Mail
Prestige Consumer's Strategic Turnaround: Assessing Brand Resilience and M&A-Driven Growth in a High-Margin Sector - AInvest
Prestige Consumer Healthcare Inc. SEC 10-Q Report - TradingView
Prestige Consumer misses Q1 revenue estimates, to acquire Pillar5 Pharma - MarketScreener
Prestige Consumer Healthcare's Fiscal 2026 Q1 Earnings: A Strategic Masterclass in Brand Diversification and Operational Excellence - AInvest
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results - GlobeNewswire
Prestige Healthcare Reports Mixed Q1 Results, Makes Strategic Eye Care Supplier Acquisition - Stock Titan
Stay Ahead of the Game With Prestige Consumer Healthcare (PBH) Q1 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
Does Prestige Consumer Healthcare Inc. fit your quant trading modelPredictive AI Engine for Smart Investing - Newser
Using Python tools to backtest Prestige Consumer Healthcare Inc. strategiesImmediate Entry Point Prediction Strategy - Newser
Prestige Consumer Healthcare Inc. Flashes Rebound Signal in Oversold ConditionStrong Buy With Technical Confidence Supported - beatles.ru
Insights Ahead: Prestige Consumer's Quarterly Earnings - 富途牛牛
1.29%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):